About Micropharma
Micropharma is a company based in Montreal (Canada) founded in 2004 by Satya Prakash was acquired by UAS Labs in December 2014. Micropharma has raised $851.24 thousand across 1 funding round from investors including UAS Labs. Micropharma operates in a competitive market with competitors including Moderna, Adaptive Biotechnologies, Generate Biomedicines, Novozymes and HOOKIPA Pharma, among others.
- Headquarter Montreal, Canada
- Founders Satya Prakash
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Micropharma
Micropharma has successfully raised a total of $851.24K through 1 strategic funding round. The most recent funding activity was a Seed round of $851.24 thousand completed in January 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Micropharma
Micropharma has secured backing from 1 investor. Prominent investors backing the company include UAS Labs.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Clinical research and probiotic fermentation services are provided.
|
Locked | Locked | Locked |
Investor details for Micropharma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Micropharma
Investment portfolio details for Micropharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Micropharma
Detailed financials for Micropharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Micropharma Comparisons
Peer comparison for Micropharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Micropharma
Micropharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Adaptive Biotechnologies, Generate Biomedicines, Novozymes and HOOKIPA Pharma, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| Locked | Locked | Locked |
Clinical diagnostics and drug discovery for immune diseases are provided.
|
|
| Locked | Locked | Locked |
Developer of novel protein-based therapeutics using machine learning and biological engineering
|
|
| Locked | Locked | Locked |
Biosolutions and enzymes are developed for biotechnology applications across industries.
|
|
| Locked | Locked | Locked |
Developer of immunotherapies for the treatment of infectious diseases and cancer
|
|
| Locked | Locked | Locked |
Therapeutics for inflammatory diseases, COVID-19, and cancer are developed.
|
Detailed competitors of Micropharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Micropharma
Complete news archive for Micropharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Micropharma
Micropharma was founded in 2004 and raised its 1st funding round 9 years after it was founded.
Micropharma is headquartered in Montreal, Canada. It is registered at Montreal, Quebec, Canada.
Micropharma is a funded company, having raised a total of $851.24K across 1 funding round to date.
Micropharma was founded in 2004 in Montreal, Canada, within the biotherapeutics sector focused on metabolic diseases. Bacteria are discovered and developed as treatments through the proprietary ProSelect platform, which identifies strains expressing targeted phenotypic traits in metabolic pathways. Fermentation and optimization techniques are applied to enhance trait over-expression. Cardioviva, a bile-salt-hydrolase active bacterium, was developed. The company was acquired by UAS Labs in 2014.
Micropharma's top competitors include Moderna, Novozymes and Adaptive Biotechnologies.
Micropharma has 1 investor. Key investors include UAS Labs.